STAT3 was suggested to be a mediator connecting inflammation and cancer progression, in which silencing of the STAT3 was found to limit CRC cell growth and induce cell death at the G2/M stage [43, 44]. This evidence concerns the gene STAT3 and colorectal carcinoma.